Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Newlink Genetics Cor (NLNK)

Newlink Genetics Cor (NLNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,232
  • Shares Outstanding, K 37,328
  • Annual Sales, $ 12,470 K
  • Annual Income, $ -53,600 K
  • 60-Month Beta 1.24
  • Price/Sales 82.48
  • Price/Cash Flow N/A
  • Price/Book 0.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.28
  • Number of Estimates 1
  • High Estimate -0.28
  • Low Estimate -0.28
  • Prior Year -0.28
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.50 +4.35%
on 02/13/20
2.40 -35.00%
on 01/21/20
-0.43 (-21.61%)
since 01/14/20
3-Month
1.49 +4.70%
on 11/18/19
3.60 -56.67%
on 12/26/19
-0.06 (-3.70%)
since 11/14/19
52-Week
1.13 +38.05%
on 10/02/19
3.60 -56.67%
on 12/26/19
+0.08 (+5.41%)
since 02/14/19

Most Recent Stories

More News
SmarTrend Watching for Potential Pullback in Shares of Newlink Genetics After 7.93% Gain

Newlink Genetics (NASDAQ:NLNK) traded in a range yesterday that spanned from a low of $1.67 to a high of $1.78. Yesterday, the shares gained 7.9%, which took the trading range above the 3-day high of...

NLNK : 1.56 (-6.59%)
Newlink Genetics Set to Possibly Pullback After Yesterday's Rally of 6.85%

Newlink Genetics (NASDAQ:NLNK) traded in a range yesterday that spanned from a low of $2.22 to a high of $2.38. Yesterday, the shares gained 6.8%, which took the trading range above the 3-day high of...

NLNK : 1.56 (-6.59%)
Company News For Dec 26, 2019

Companies In The News Are: SSNT, NLNK, CVM, AXE

AXE : 98.25 (-0.31%)
CVM : 14.22 (-1.93%)
NLNK : 1.56 (-6.59%)
SSNT : 3.03 (-0.33%)
Newlink Genetics Rises 24.10% on Heavy Volume: Watch For Potential Pullback

Newlink Genetics (NASDAQ:NLNK) traded in a range yesterday that spanned from a low of $2.07 to a high of $2.60. Yesterday, the shares gained 24.1%, which took the trading range above the 3-day high of...

NLNK : 1.56 (-6.59%)
NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207

NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company has entered into an exclusive worldwide license agreement with Ellipses Pharma Limited (Ellipses) for the development of and...

NLNK : 1.56 (-6.59%)
NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO(R))

NewLink Genetics Corporation (NASDAQ:NLNK) announced today that, after priority review, the FDA has granted approval of ERVEBO(R), or Zaire Ebola virus vaccine V920 (rVSVDG-ZEBOV-GP), as confirmed by our...

NLNK : 1.56 (-6.59%)
MRK : 82.65 (+0.83%)
Do Options Traders Know Something About NewLink Genetics (NLNK) Stock We Don't?

Investors need to pay close attention to NewLink Genetics (NLNK) stock based on the movements in the options market lately.

NLNK : 1.56 (-6.59%)
NewLink Genetics Responds to Proposal from Evercel

NewLink Genetics Corporation (NASDAQ:NLNK) ("NewLink" or the "Company") today publicly announced its rejection of the unsolicited acquisition proposal received on November 5, 2019 from Evercel, Inc. ("Evercel")...

NLNK : 1.56 (-6.59%)
EVRC : 2.4000 (+3.45%)
Evercel Announces Rejected Offer to Acquire NewLink Genetics

Evercel, Inc. ("Evercel") (OTC: EVRC) has made an offer to acquire NewLink Genetics Corporation ("NewLink") (NASDAQ: NLNK).

EVRC : 2.4000 (+3.45%)
NLNK : 1.56 (-6.59%)
Newlink Genetics Set to Possibly Pullback After Yesterday's Rally of 12.50%

Newlink Genetics (NASDAQ:NLNK) traded in a range yesterday that spanned from a low of $1.53 to a high of $1.75. Yesterday, the shares gained 12.5%, which took the trading range above the 3-day high of...

NLNK : 1.56 (-6.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade NLNK with:

Business Summary

NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications. NewLink...

See More

Key Turning Points

2nd Resistance Point 1.72
1st Resistance Point 1.64
Last Price 1.56
1st Support Level 1.51
2nd Support Level 1.46

See More

52-Week High 3.60
Fibonacci 61.8% 2.66
Fibonacci 50% 2.37
Fibonacci 38.2% 2.07
Last Price 1.56
52-Week Low 1.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar